Oslo, 4 February 2025: Board member Kathrine Elisabeth Gamborg Andreassen has informed the board of directors of Observe Medical ASA (the "Company" or "Observe Medical") that she will resign from the Company's board of directors, effective 5 February 2025, in order to focus on her responsibilities as CEO of Navamedic ASA.

Following the resignation, the board of directors will continue to constitute a quorum and is comprised of Terje Bakken (chair), Eskild Endrerud (board member) and Line Tønnessen (board member).

The appointment of any replacement director is expected to be considered in relation to the Company's annual general meeting on 28 May 2025 (the "AGM"). Ms. Gamborg Andreassen has also informed that she has offered herself for election to the Company's nomination committee at the AGM.

For further information, please contact:

Jørgen Mann

CEO

Observe Medical

Mobile: +45 408 67 558

E-mail: jorgen.mann@observemedical.com

Johan Fagerli

CFO

Observe Medical

Mobile: +47 958 12 765

E-mail: johan.fagerli@observemedical.com

This information is subject to the disclosure requirements pursuant to article 19 of the EU Market Abuse Regulation and section 5-12 of the Norwegian Securities Trading Act.

About Observe Medical:

Observe Medical is a Nordic medtech company that develops, markets, and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy, and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in urine measurement and ultrasound, in combination with targeted M&A and distribution. Observe Medical is working with a network of leading distributors to provide outstanding solutions for healthcare professionals globally.

The Company is headquartered in Oslo, Norway.

Further information is available at www.observemedical.com.